Treatment of lung cancer
245 results
101 - 200
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer New
Breast cancer - Palliative endobronchial brachytherapy for non‐small cell lung cancer New search for studies and content updated (no change to conclusions)
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Psychosocial interventions for reducing fatigue during cancer treatment in adults Stable (no update expected for reasons given in 'What's new')
Daily multivitamins have minimal, if any, effect on preventing cancer in men and do not affect mortality- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer New search for studies and content updated (conclusions changed)
- Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases: Cochrane systematic review
- Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma Edited (no change to conclusions)
- Intermittent versus continuous androgen suppression for prostatic cancer Edited (no change to conclusions)
- Chemotherapy for brain metastases from small cell lung cancer: Cochrane systematic review
- Antibody induction therapy for lung transplant recipients New
- Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults Stable (no update expected for reasons given in 'What's new')
- Biomedical risk assessment as an aid for smoking cessation
- Prolonged cough in adults
- Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): Cochrane systematic review
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer Edited (no change to conclusions)
- Concurrent chemoradiotherapy in non-small cell lung cancer: Cochrane systematic review
- PSA screening has marginal effect on mortality in European study (ERSPC)
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Management of adverse effects of radiotherapy
- Short term benefits for laparoscopic colorectal resection Edited (no change to conclusions)
- Vitamins E and C and selenium do not reduce risk of prostate or total cancer in men
- Anticoagulation for perioperative thromboprophylaxis in people with cancer Edited (no change to conclusions)
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer Edited (no change to conclusions)
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy: Cochrane systematic review
- Organ transplant recipient in primary health care
- Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
- USPSTF review of the benefits and harms of menopausal hormone therapy
- Guidelines for end of life care (ACP)
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer New search for studies and content updated (no change to conclusions)
- Lymphangitis
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer New search for studies and content updated (no change to conclusions)
- Interventions for the management of malignant pleural effusions: a network meta‐analysis New search for studies and content updated (conclusions changed)
- Carotenoids and omega-3 fatty acids do not reduce risk of advanced AMD
- Second‐line chemotherapy for non‐small cell lung cancer Edited (no change to conclusions)
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Haemoptysis
- Radiotherapy for early breast cancer: Cochrane systematic review
- Platinum‐containing regimens for triple‐negative metastatic breast cancer Edited (no change to conclusions)
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents Edited (no change to conclusions)
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism Edited (no change to conclusions), comment added to review
- Alemtuzumab for patients with chronic lymphocytic leukaemia: Cochrane systematic review
- Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients New
- Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults: Cochrane systematic review
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Antidepressants for depression in medical illness: Cochrane systematic review
- Anaesthetic techniques for risk of malignant tumour recurrence Edited (no change to conclusions)
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Percutaneous ethanol injection for liver metastases New search for studies and content updated (no change to conclusions)
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent New search for studies and content updated (no change to conclusions)
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy New search for studies and content updated (no change to conclusions)
- Impact of PSA screening on quality of life
- Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under: Cochrane systematic review
- Telephone interventions for symptom management in adults with cancer New
- Immunotherapy for advanced renal cell cancer: Cochrane systematic review
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease New
- Fewer overall hospital days with use of indwelling pleural catheters vs pleurodesis for malignant effusions
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer Stable (no update expected for reasons given in 'What's new')
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer Edited (no change to conclusions)
- Palliative treatment
- Mindfulness‐based stress reduction for women diagnosed with breast cancer New
- Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis New
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population Edited (no change to conclusions)
- Alcoholic liver disease (ALD)
- Platinum‐containing regimens for metastatic breast cancer Stable (no update expected for reasons given in 'What's new')
- PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer: Cochrane systematic review (diagnostic test accuracy)
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism New
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma New
- Topical tretinoin may increase all-cause mortality
- Pneumonia
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer) New
- Golimumab for rheumatoid arthritis
- Interventions for fatigue and weight loss in adults with advanced progressive illness
- Genetic test results that identify increased risk do not change behavior
- Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma New
- PSA for screening of prostate cancer
- Lymphomas
- Antitubercular medication in ambulatory care
- Unintentional weight loss in adults
- Antifibrinolytic therapy to reduce haemoptysis from any cause New search for studies and content updated (no change to conclusions)
- Interventions for preventing neuropathy caused by cisplatin and related compounds: Cochrane systematic review
- Targeted therapy for advanced renal cell carcinoma New search for studies and content updated (no change to conclusions)
- Long term hormone therapy for perimenopausal and postmenopausal women for chronic conditions
- Radiotherapy and surgery in early breast cancer